Cargando…
Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment
Triple-negative breast cancer (TNBC) has been listed as one of the most fatal diseases, and no effective targeting treatment is clinically available. Although CD44-targeting hyaluronic acid (HA) has been utilized as targeting ligands in many studies, no facile ways have been developed through HA sel...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695327/ https://www.ncbi.nlm.nih.gov/pubmed/36432652 http://dx.doi.org/10.3390/pharmaceutics14112461 |
_version_ | 1784838028994281472 |
---|---|
author | Li, Yingpeng Liu, Liang Shang, Hongtao Feng, Xuchen Fan, Ni Wang, Jingyu Wu, Yuqi Chen, Yatong Chu, Xinhong Zhong, Min Sun, Yujiao Fu, Hui Huang, Wei Li, Yunfei |
author_facet | Li, Yingpeng Liu, Liang Shang, Hongtao Feng, Xuchen Fan, Ni Wang, Jingyu Wu, Yuqi Chen, Yatong Chu, Xinhong Zhong, Min Sun, Yujiao Fu, Hui Huang, Wei Li, Yunfei |
author_sort | Li, Yingpeng |
collection | PubMed |
description | Triple-negative breast cancer (TNBC) has been listed as one of the most fatal diseases, and no effective targeting treatment is clinically available. Although CD44-targeting hyaluronic acid (HA) has been utilized as targeting ligands in many studies, no facile ways have been developed through HA self-assembly at the nanoparticle surface. Herein, we reported N-isopropylacrylamide-grafted chitosan-based nanoparticles self-assembling with HA (HA-NPs) through electrostatic forces and loaded with curcumin (CUR). The HA-NPs displayed pH-responsive properties due to the chemical modification of chitosan, and the preparation process was optimized by central composite design–response surface methodology. HA anchorage confers the vehicle with tumor-targeting capability. HA-NPs displayed more robust effects of inhibiting TNBC primary tumor growth than free CUR and a plain counterpart but without increased systemic cytotoxicity. In addition, in vivo pharmacokinetic studies showed that HA-NPs significantly increased the in vivo residence time of free CUR and improved the bioavailability of CUR. These findings suggested that chitosan-based HA-NPs may provide a feasible and unique strategy to achieve CD44 targeting and enhance its efficacy in vivo for the treatment of advanced TNBC. |
format | Online Article Text |
id | pubmed-9695327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96953272022-11-26 Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment Li, Yingpeng Liu, Liang Shang, Hongtao Feng, Xuchen Fan, Ni Wang, Jingyu Wu, Yuqi Chen, Yatong Chu, Xinhong Zhong, Min Sun, Yujiao Fu, Hui Huang, Wei Li, Yunfei Pharmaceutics Article Triple-negative breast cancer (TNBC) has been listed as one of the most fatal diseases, and no effective targeting treatment is clinically available. Although CD44-targeting hyaluronic acid (HA) has been utilized as targeting ligands in many studies, no facile ways have been developed through HA self-assembly at the nanoparticle surface. Herein, we reported N-isopropylacrylamide-grafted chitosan-based nanoparticles self-assembling with HA (HA-NPs) through electrostatic forces and loaded with curcumin (CUR). The HA-NPs displayed pH-responsive properties due to the chemical modification of chitosan, and the preparation process was optimized by central composite design–response surface methodology. HA anchorage confers the vehicle with tumor-targeting capability. HA-NPs displayed more robust effects of inhibiting TNBC primary tumor growth than free CUR and a plain counterpart but without increased systemic cytotoxicity. In addition, in vivo pharmacokinetic studies showed that HA-NPs significantly increased the in vivo residence time of free CUR and improved the bioavailability of CUR. These findings suggested that chitosan-based HA-NPs may provide a feasible and unique strategy to achieve CD44 targeting and enhance its efficacy in vivo for the treatment of advanced TNBC. MDPI 2022-11-15 /pmc/articles/PMC9695327/ /pubmed/36432652 http://dx.doi.org/10.3390/pharmaceutics14112461 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Yingpeng Liu, Liang Shang, Hongtao Feng, Xuchen Fan, Ni Wang, Jingyu Wu, Yuqi Chen, Yatong Chu, Xinhong Zhong, Min Sun, Yujiao Fu, Hui Huang, Wei Li, Yunfei Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment |
title | Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment |
title_full | Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment |
title_fullStr | Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment |
title_full_unstemmed | Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment |
title_short | Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment |
title_sort | self−assembling anchorage of hyaluronic acid on the nanoparticle surface confers superiority of triple negative breast cancer treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695327/ https://www.ncbi.nlm.nih.gov/pubmed/36432652 http://dx.doi.org/10.3390/pharmaceutics14112461 |
work_keys_str_mv | AT liyingpeng selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT liuliang selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT shanghongtao selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT fengxuchen selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT fanni selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT wangjingyu selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT wuyuqi selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT chenyatong selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT chuxinhong selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT zhongmin selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT sunyujiao selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT fuhui selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT huangwei selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment AT liyunfei selfassemblinganchorageofhyaluronicacidonthenanoparticlesurfaceconferssuperiorityoftriplenegativebreastcancertreatment |